About 1 result found for searched term "Elotuzumab" (0.137 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M22514 | Elotuzumab | Others |
| BMS 901608; PDL 063; HuLuc 63 | ||
| Elotuzumab is a First-in-Class monoclonal antibody directed against the SLAMF7 receptor, it specifically binds to signaling lymphocyte activating molecule family member 7 (SLAMF7) and activates the body's immune response to attack and kill multiple myeloma cells. Elotuzumab exerts its anti-myeloma effects mainly through ADCC and activation of NK cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
